The potential of herbal extracts to inhibit SARS-CoV-2: a pilot study

BACKGROUND: Herbal medicinal products have a long-standing history of use in the therapy of common respiratory infections. We sought to assess the potential of five validated herbal extracts regarding their ability to restrict SARS-CoV-2 replication in vitro: Bronchipret thyme-ivy (BRO TI), Bronchip...

Descripción completa

Detalles Bibliográficos
Autores principales: De Pellegrin, Michela Luisa, Rohrhofer, Anette, Schuster, Philipp, Schmidt, Barbara, Peterburs, Philipp, Gessner, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937545/
http://dx.doi.org/10.1186/s40816-021-00264-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937545/
http://dx.doi.org/10.1186/s40816-021-00264-6

Ejemplares similares